Item 5.03.   Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Years.

Effective March 28, 2022, Cannabics Pharmaceuticals Inc., a Nevada corporation (the "Company"), changed its name to "CNBX Pharmaceuticals Inc." (the "Name Change") by filing a Certificate of Amendment (the "Certificate of Amendment") to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada. The Name Change was approved unanimously by the Company's board of directors and by the holder of the majority of the Company's issued and outstanding shares of common stock on February 14, 2022.

A copy of the Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference herein.

The Name Change does not affect the rights of the Company's security holders and the Company's common stock will continue to trade on the OTCQB under the symbol "CNBX". Following the Name Change, the stock certificates of the common stock reflecting the former name of the Company will continue to be valid.




Item 8.01. Other Events.

On March 28, 2022, the Company issued a press release announcing the Name Change. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.





Exhibit No.     Exhibit Description

(d) Exhibits
    3.1           Certificate of Amendment to Amended and Restated Articles of
                Incorporation
    99.1          Press release March 28, 2022
    104         Cover Page Interactive Data File (the cover page XBRL tags are
                embedded within the inline XBRL document)








  2

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 28, 2022



                     CNBX PHARMACEUTICALS INC.


                     By: /s/ Eyal Barad
                         Eyal Barad
                         Chief Executive Officer












  3

© Edgar Online, source Glimpses